Programme
The exact programme will be released soon!
To get a glimpse into possible topics, check out our list of confimed speakers.
Tuesday, September 24th, 2024
Registration
OPENING OF THE CONFERENCE
Rector, University of Tartu
Welcome by Mait Metspalu
Director of the Institute of Genomics, University of Tartu
Medical genomics in healthcare
Stephen Kingsmore
KEYNOTE
President and CEO of Rady Children's Institute for Genomic Medicine, USA
“Solving the problem of rare childhood genetic disease with genome sequencing”
Janis KlovinsProfessor at the Latvian Biomedical Research and Study Centre, Latvia
"Building the Latvian Genomic Reference: Insights into Genetic Diversity and Applications of Disease Prediction"
Coffee break
Genetic epidemiology
Peter Visscher
Professor at the University of Queensland, Australia
“Height as a model trait in human complex trait genetics”
Professor at the University of Lausanne, Switzerland and honorary senior lecturer at at the University of Exeter, United Kingdom
"Mendelian Randomisation: connecting diseases, omics layers, drugs and even humans"
Professor at TUM School of Medicine and Health, Germany
"Restless Legs Syndrome insights into genetic architecture, disease biology, and risk prediction"
Lunch Break
Psychiatric genomics
Naomi Wray
Professor at the University of Oxford, United Kingdom and University of Queensland, Australia
“Important opportunities for polygenic risk scores in psychiatry need in-clinic research”
Wouter PeyrotAssistant Professor in Statistical and Psychiatric Genetics, Amsterdam University Medical Center, Netherlands
"Towards clinical implementation of genetic risk profiles using DDx-PRS"
Katherine MuslinerAssociate professor at the Aarhus University and Aarhus University Hospital, Denmark
"Polygenic risk and clinical outcomes in patients with severe mental illness"
Coffee break
Pharmacogenomics
Andrea Gaedigk
Director at Pharmacogenetics Core Laboratory and PharmVar, professor at the Univeristy of Missouri, United Stated of America
"Pharmacogenetics of CYP2D6: why you should care about this gene and PharmVar"
Professor at the University Hospital of RWTH Aachen, Germany
"Precision dosing: phenotypic model based prediction of pharmacogenetic dose adjustments in situations of polypharmacy"
Professor at the Saarland University, Germany
"Decoding the Complexity of Drug-Drug-Gene Interactions: A Pathway to Safer, Personalised Treatment"
Dinner at Estonian National Museum
Wednesday, September 25th, 2024
Microbiome
Tommi Vatanen
Associate professor at the University of Helsinki, Finland
“Interplay between gut bacteria, secondary metabolites and infant development”
Professor and director at the Karolinska Institute, Sweden
“Large-scale translational microbiome research - the value of population-based metagenomic data from the perspective of personalized medicine”
Associate Professor, University College Cork and CEO at SeqBiome, Ireland
“Disentangling the microbiome of IBD and the role of machine learning”
Coffee break
Technological advances in the forefront of science
Dalia Daujotyte
Senior Director, Global Product Management at Illumina
“Illumina Protein Prep - Expand your studies across multiple omes - with NGS-based proteomics”
Neil WardVP and General Manager of PacBio for Europe, the Middle East, and Africa
“Comprehensive variant detection with HiFi sequencing”
Lunch Break
Population genetics, Evolutionary and functional genomics
Tuuli Lappalainen
Professor at the SciLifeLab, KTH Royal Institute of Technology, Sweden and New York Genome Center, United States of America
“Functional variation in the human genome: Lessons from the transcriptome”
Max Planck Institute, Germany
“Ancient Genomes of Neandertals and Modern Humans in Europe”
Professor at the KU Leuven, Belgium, associate professor at the University of Tartu, Estonia
“Impact of medieval demography and plague pandemics on the genetic make up of Northern Europe”
Coffee break
Genomics based Clinical Trials
Paolo Rossi
Director of the Epidemiology Unit, Azienda USL - IRCCS di Reggio Emilia, Italy
“Theory and practice of risk-based screening: insights from MyPeBS trial”
Melanoma Patient Network Europe, Stockholm School of Economics, Sweden
“Building multi-stakeholder ecosystems to implement precision medicine in Europe- learnings from DRUP-Like Clinical Trials”
Dr, MD, Hannover Medical School, Germany
“Expediting genetic diagnosis in critically ill children by ultra-rapid genome sequencing”
Closing remarks
Announcing the winner of Artur Lind Scholarship